Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Esperion Therapeutics, Inc. (ESPR)  
$2.68 0.06 (2.29%) as of 4:30 Thu 3/28


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 84,571,000
Market Cap: 226.65(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.7304 - $3.08
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Esperion Therapeutics is a pharmaceutical company focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Co.'s first two products were approved by the U.S. Food and Drug Administration, European Medicines Agency, and Swiss Agency for Therapeutic Products. Bempedoic acid and the bempedoic acid / ezetimibe combination tablets are oral, once-daily, non-statin, LDL-C lowering medicines for patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 59,611 74,217
Total Buy Value $0 $0 $86,148 $171,738
Total People Bought 0 0 3 4
Total Buy Transactions 0 0 4 7
Total Shares Sold 0 0 4,256 51,775
Total Sell Value $0 $0 $5,666 $239,770
Total People Sold 0 0 3 4
Total Sell Transactions 0 0 8 26
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 250
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Foody Joanne M. Chief Medical Officer   •       –      –    2024-03-14 4 A $0.00 $0 D/D 150,000 277,064     -
   Warren Eric Chief Commercial Officer   •       –      –    2024-03-14 4 A $0.00 $0 D/D 100,000 168,318     -
   Looker Benjamin General Counsel   •       –      –    2024-03-14 4 A $0.00 $0 D/D 100,000 183,663     -
   Halladay Benjamin Chief Financial Officer   •       –      –    2024-03-14 4 A $0.00 $0 D/D 170,000 243,936     -
   Koenig Sheldon L. President and CEO   •       •      –    2024-03-14 4 A $0.00 $0 D/D 454,000 766,816     -
   Warren Eric Chief Commercial Officer   •       –      –    2023-09-20 4 S $1.25 $924 D/D (742) 68,318 -76%     
   Warren Eric Chief Commercial Officer   •       –      –    2023-08-18 4 S $1.41 $344 D/D (243) 69,060 -95%     
   Warren Eric Chief Commercial Officer   •       –      –    2023-07-19 4 S $1.59 $168 D/D (106) 69,303 19%     
   Warren Eric Chief Commercial Officer   •       –      –    2023-06-21 4 S $1.48 $894 D/D (603) 69,409 45%     
   Carroll J Martin Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 5,150 41,650     -
   Rocamboli Stephen Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 5,150 13,261     -
   Woody Tracy M Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 5,150 33,566     -
   Fuhrman Alan Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 5,150 30,404     -
   Fischer Seth H.z. Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 5,150 5,150     -
   Vitullo Nicole Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 5,150 36,918     -
   Gotto Antonio M Jr MD D Phil Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 5,150 28,599     -
   Shepard Jay Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 5,150 28,599     -
   Warren Eric Chief Commercial Officer   •       –      –    2023-05-17 4 S $1.62 $356 D/D (219) 70,012 40%     
   Carroll J Martin Director   –       •      –    2023-05-11 4 B $1.57 $36,285 D/D 23,091 36,500 2.39 -23%     
   Carroll J Martin Director   –       •      –    2023-05-10 4 B $1.49 $12,545 D/D 8,409 13,409 2.39 -15%     
   Rocamboli Stephen Director   –       •      –    2023-05-10 4 B $1.50 $12,126 D/D 8,111 8,111 2.39 -15%     
   Koenig Sheldon L. President and CEO   •       •      –    2023-05-09 4 B $1.26 $25,192 D/D 20,000 312,816 2.81 -9%     
   Foody Joanne M. Chief Medical Officer   •       –      –    2023-04-19 4 S $1.27 $1,192 D/D (938) 127,064 -21%     
   Warren Eric Chief Commercial Officer   •       –      –    2023-04-19 4 S $1.28 $147 D/D (115) 70,231 -21%     
   Looker Benjamin General Counsel   •       –      –    2023-04-19 4 S $1.27 $1,641 D/D (1,290) 83,663 -21%     

  250 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed